Clinical Research Directory
Browse clinical research sites, groups, and studies.
Benefit of Ethanol Sclerotherapy of Endometriomas Before Ovarian Stimulation on Pregnancy Rates in IVF/ICSI
Sponsor: Poissy-Saint Germain Hospital
Summary
Evaluation of progressive pregnancy rates (with an embryo with cardiac activity at 12 weeks), on a first attempt at IVF/ICSI (fresh and frozen embryo transfers) following the discovery of one or two endometrioma(s) of 30 to 80 mm, without a history of cystectomy, and comparison between the two groups: ethanol sclerotherapy and therapeutic abstention
Key Details
Gender
FEMALE
Age Range
18 Years - 43 Years
Study Type
INTERVENTIONAL
Enrollment
174
Start Date
2025-06-01
Completion Date
2029-06-01
Last Updated
2025-03-14
Healthy Volunteers
No
Conditions
Interventions
ethanol sclerotherapy
The originality of this project consists in evaluating the effectiveness of ethanol sclerotherapy of endometrioma(s) in infertile patients before IVF/ICSI, excluding patients who have previously had an ovarian cystectomy. To date, no prospective randomized comparative study between ethanol sclerotherapy of endometriomas and therapeutic abstention has been carried out.